The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells

Mechanisms of Development

Volumn 122, Issue 9, 2005, Pages 1034-1042

  Bahrami, Ahmad R ^a,b   Matin, Maryam M ^a,b   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Embryonal carcinoma; Germ cell tumours; Pluripotent

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27; RETINOIC ACID;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CELL DIFFERENTIATION; CELL FUNCTION; CELL FUSION; CONTROLLED STUDY; EMBRYO; EMBRYONAL CARCINOMA; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYBRID CELL; NERVE CELL DIFFERENTIATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENE; UPREGULATION;

BASE SEQUENCE; CARCINOMA, EMBRYONAL; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION; HUMANS; NEURONS; PLASMIDS; PLURIPOTENT STEM CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; TRETINOIN; TUMOR STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 23144452882     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mod.2005.04.011     Document Type: Article

References (41)

1. A. Alkarain, R. Jordan, and J. Slingerland p27 deregulation in breast cancer: prognostic significance and implications for therapy J. Mammary Gland Biol. Neoplasia 9 2004 67 80
2. P.W. Andrews Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro Dev. Biol. 103 1984 285 293
3. P.W. Andrews Teratocarcinomas and human embryology: pluripotent human EC cell lines Acta Pathol. Microbiol. Immunol. Scand. 106 1998 158 168
4. P.W. Andrews, P.N. Goodfellow, L.H. Shevinsky, D.L. Bronson, and B.B. Knowles Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture Int. J. Cancer 29 1982 523 531
5. P.W. Andrews, I. Damjanov, D. Simon, G.S. Banting, C. Carlin, and N.C. Dracopoli Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro Lab. Invest. 50 1984 147 162
6. P.W. Andrews, E. Nudelman, S. Hakomori, and B.A. Fenderson Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR) Differentiation 43 1990 131 138
7. N.B. Atkin, and M.C. Baker Specific chromosome change, i(12p), in testicular tumours? Lancet 2 1982 1349
8. G. Baldassarre, A. Boccia, P. Bruni, C. Sandomenico, M.V. Barone, and S. Pepe Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27 Cell Growth Differ. 11 2000 517 526
9. J. Boonstra Progression through the G1-phase of the on-going cell cycle J. Cell Biochem. 90 2003 244 252
10. A. Borriello, V.D. Pietra, M. Criscuolo, A. Oliva, G.P. Tonini, and A. Iolascon p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation Oncogene 19 2000 51 60
11. C. Bouchard, K. Thieke, A. Maier, R. Saffrich, J. Hanley-Hyde, and W. Ansorge Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 Eur. Mol. Biol. Org. J. 18 1999 5321 5333
12. T. Burdon, A. Smith, and P. Savatier Signalling, cell cycle and pluripotency in embryonic stem cells Trends Cell Biol. 12 2002 432 438
13. I. Chambers, D. Colby, M. Robertson, J. Nichols, S. Lee, and S. Tweedie Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells Cell 113 2003 643 655
14. A. Dimberg, F. Bahram, I. Karlberg, L.G. Larsson, K. Nilsson, and F. Oberg Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1) Blood 99 2002 2199 2206
15. J.S. Draper, C. Pigott, J.A. Thomson, and P.W. Andrews Surface antigens of human embryonic stem cells: changes upon differentiation in culture J. Anat. 200 2002 249 258
16. J.S. Draper, K. Smith, P. Gokhale, H.D. Moore, E. Maltby, and J. Johnson Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells Nat. Biotechnol. 22 2004 53 54
17. C. Duran, P.J. Talley, J. Walsh, C. Pigott, I.E. Morton, and P.W. Andrews Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: partial retention of a pluripotent phenotype Int. J. Cancer 93 2001 324 332
18. G.S. Eisenbarth, F.S. Walsh, and M. Nirenberg Monoclonal antibody to a plasma membrane antigen of neurons Proc. Natl Acad. Sci. USA 76 1979 4913 4917
19. B.A. Fenderson, P.W. Andrews, E. Nudelman, H. Clausen, and S. Hakomori Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells Dev. Biol. 122 1987 21 34
20. M. Hall, and G. Peters Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer Adv. Cancer Res. 68 1996 67 108
21. J.K. Henderson, J.S. Draper, H.S. Baillie, S. Fishel, J.A. Thomson, and H. Moore Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens Stem Cells 20 2002 329 337
22. M. Hoglund, B. Johansson, J. Pedersen-Bjergaard, P. Marynen, and F. Mitelman Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2 Blood 87 1996 324 330
23. G. Kohler, and C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 1975 495 497
24. S.M. Kraggerud, R.I. Skotheim, J. Szymanska, M. Eknaes, S.D. Fossa, and A.E. Stenwig Genome profiles of familial/bilateral and sporadic testicular germ cell tumors Genes Chromosomes Cancer 34 2002 168 174
25. M.H. Lee, and H.Y. Yang Regulators of G1 cyclin-dependent kinases and cancers Cancer Metastasis Rev. 22 2003 435 449
26. L.H. Looijenga, and J.W. Oosterhuis Pathobiology of testicular germ cell tumors: views and news Anal. Quant. Cytol. Histol. 24 2002 263 279
27. K.I. Matthaei, P.W. Andrews, and D.L. Bronson Retinoic acid fails to induce differentiation in human teratocarcinoma cell lines that express high levels of a cellular receptor protein Exp. Cell Res. 143 1983 471 474
28. F. Mavilio, A. Simeone, E. Boncinelli, and P.W. Andrews Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid Differentiation 37 1988 73 79
29. M.M. Mostert, M. van de Pol, J. van Echten, D. Olde Weghuis, A. Geurts van Kessel, and J.W Oosterhuis Fluorescence in situ hybridization-based approaches for detection of 12p overrepresentation, in particular i(12p), in cell lines of human testicular germ cell tumors of adults Cancer Genet. Cytogenet. 87 1996 95 102
30. H. Niwa, K. Yamamura, and J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1991 193 199
31. M.J. O'Hare Teratomas, neoplasia and differentiation: a biological overview. I. The natural history of teratomas Invest. Cell Pathol. 1 1978 39 63
32. M. Pagano, S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del Sal, and V. Chau Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 269 1995 682 685
33. G.B. Pierce Teratocarcinoma: introduction and perspectives M.I. Sherman D. Solter Teratomas and Differentiation 1975 Academic Press New York 3 12
34. H. Preclikova, V. Bryja, J. Pachernik, P. Krejci, P. Dvorak, and A. Hampl Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells Cell Growth Differ. 13 2002 421 430
35. A.A. Sandberg, A.M. Meloni, and R.F. Suijkerbuijk Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors J. Urol. 155 1996 1531 1556
36. R.J. Sheaff, M. Groudine, M. Gordon, J.M. Roberts, and B.E. Clurman Cyclin E-CDK2 is a regulator of p27Kip1 Genes Dev. 11 1997 1464 1478
37. L.H. Shevinsky, B.B. Knowles, I. Damjanov, and D. Solter Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells Cell 30 1982 697 705
38. R.I. Skotheim, O. Monni, S. Mousses, S.D. Fossa, O.P. Kallioniemi, and R.A. Lothe New insights into testicular germ cell tumorigenesis from gene expression profiling Cancer Res. 62 2002 2359 2364
39. J. Slingerland, and M. Pagano Regulation of the cdk inhibitor p27 and its deregulation in cancer J. Cell Physiol. 183 2000 10 17
40. D. Solter, and B.B. Knowles Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1) Proc. Natl Acad. Sci. USA 75 1978 5565 5569
41. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, and V.S. Marshall Embryonic stem cell lines derived from human blastocysts Science 282 1998 1145 1147